Daiichi Sankyo
Top stories
- AstraZeneca, Daiichi Sankyo partner with Summit to test cancer drug combo3 outlets · 2026-10-02 11:53 UTC
Latest
- AstraZeneca, Daiichi Sankyo partner with Summit to test cancer drug combosowetan.co.za · 2026-10-02 07:54 UTC · 2 more reports
- NTK Appeals Tokyo Court's Dismissal of ¥203.3bn Damages Claim Against Daiichi Sankyotokyobrief.com · 2026-09-28 12:01 UTC · story

- Daiichi Sankyo, MSD withdraw cancer drug applicationpharmaceutical-business-review.com · 2026-09-28 10:40 UTC · story
- Daiichi Sankyo withdraws application for rapid approval of lung cancer treatment drug in the USassets.wor.jp · 2026-09-28 06:32 UTC · story
- Merck and Daiichi Sankyo withdraw FDA approval application for new lung cancer drug 'Ifinatamab Deruxtecan'cdn.pharmnews.com · 2026-09-28 00:11 UTC · story